Golden
IP Group

IP Group

IP Group is a company that develops intellectual property-based businesses, is headquartered in London, United Kingdom and was founded in 2001.

IP Group is a leading intellectual property commercialisation company which focuses on evolving ideas from its partner universities and turn these into businesses. They are helping to create, build, and support early-stage to mature businesses across Life Sciences, Cleantech and Technology. IP Group is supporting their portfolio companies with financial capital, strategic and commercial expertise, executive search and development, corporate finance and and capital raising, and a range of administrative services. The Group began their long-term partnership model with United Kingdom universities and replicated this approach in research institutions in United States and in 2017, they expanded into Australasia.

Investments

IP Group has raised a total of $227.4M across 3 funds. IP Group, also known as IPO in the Main Market, is a constituent of the FTSE 250 Index and being traded in the London Stock Exchange.

Timeline

People

Name
Role
Related Golden topics

Alan Aubrey

Chief Executive Officer



David Baynes

Chief Operating Officer



Dr Elaine Sullivan

Non-executive Director



Greg Smith

Chief Financial Officer



Heejae Chae

Non-executive Director



Jonathan Brooks

Non-executive Director



Mike Townend

Chief Investment Officer



Prof David Begg

Senior Independent Director



Sir Douglas Flint, CBE

Non-executive Chairman



Further reading

Title
Author
Link
Type
Date









Documentaries, videos and podcasts

Title
Date
Link





Companies

Company
CEO
Location
Products/Services

Actual Experience plc

Dave Page

London

Cloud-based analytics

Autifony Therapeutics Ltd

Charles H. Large, PhD

United Kingdom

Developing high value, novel medicines to treat serious diseases of the central nervous system

Cell Medica Ltd

Chris Nowers

United Kingdom

Cellular immunotherapy products for the treatment of cancer and infections

Ceres Power Holdings plc

Phil Caldwell

United Kingdom

Ceramic fuel cell technology for distributed generation

Steve Harris

United Kingdom

Specialty pharmaceutical company focused on respiratory disease



United Kingdom

A global pharmaceutical company focused on chronic endocrine conditions

Istesso Ltd





Design and development of novel therapeutic drugs

Dr Gordon Sanghera

United Kingdom

Electronics-based DNA/RNA sequencing technology

Oxford Sciences Innovation plc



United Kingdom

Commercialization of intellectual property from the University of Oxford

PsiOxus Therapeutics Ltd

Dr John Beadle

United Kingdom

Systemic delivery of tumour-targeted oncolytic immune therapeutics

References